Related Experiment Video
Updated: Jul 1, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
High-Risk Aortic Plaque in Atrial Fibrillation: A Therapeutic Dilemma
Shaniza Haniff1, Ashwin Shive Gowda2, Nawfal Al-Khafaji3
1Internal Medicine, University at Buffalo, New York, USA.
Insights
Managing atrial fibrillation (AF) and high-risk aortic plaques is challenging due to stroke risks. This case demonstrates successful management using anticoagulation, statins, and surveillance, avoiding thromboembolic complications.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Neurology
Background:
- Atrial fibrillation (AF) is a common arrhythmia linked to aortic plaques, increasing embolic event risk, including stroke.
- Management strategies for patients with both AF and high-risk aortic plaques are not well-established.
- A 77-year-old female presented with new-onset AF and a high-risk ascending aorta plaque.
Abstract:
Atrial fibrillation (AF), a common cardiac arrhythmia, is often accompanied by aortic plaques that are associated with an increased risk of embolic events, including stroke. Evidence-based management in this population is lacking. We present a case of a 77-year-old female with new-onset AF who was found to have a high-risk aortic plaque at the level of the ascending aorta and ostium of the right coronary artery. Definitive treatment for AF, cardioversion, high-risk aortic plaque, and cardiothoracic surgery, could not be performed due to the elevated risk of ischemic stroke and embolic complications. Based on existing literature, the cardiologist and cardiothoracic surgeon collaboratively decided to treat both conditions with anticoagulation, statin, and periodic imaging surveillance of high-risk aortic plaque. The patient was successfully managed without any thromboembolic complications despite an elevated risk. This case report provides a comprehensive literature review of managing AF with high-risk aortic plaques. It delves into the integration of anticoagulation and antiplatelet agents in the dual challenge of stroke prevention in AF and mitigating embolic risks associated with aortic plaques. To date, there has been no consensus on managing AF and high-risk aortic plaques; thus, we aim to fill this gap.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

